Quarterly report pursuant to Section 13 or 15(d)

Goodwill and In-process R&D (Details)

v3.20.1
Goodwill and In-process R&D (Details) - USD ($)
3 Months Ended 12 Months Ended
Mar. 31, 2020
Dec. 31, 2017
Dec. 31, 2019
Goodwill and In-Process R&D      
Goodwill $ 1,452,338   $ 1,452,338
Goodwill Gross     2,200,000
Goodwill, Fair Value 1,500,000    
Goodwill impairment loss $ 0    
Impairment loss     $ 700,000
Pelican Therapeutics, Inc.      
Goodwill and In-Process R&D      
Goodwill   $ 2,200,000  
In-process R&D   $ 5,900,000